Volume 94, Issue 3, Pages (September 2018)

Slides:



Advertisements
Similar presentations
Computer Class – Summer /6/2015 1:13 PM North American Countries Anguilla Antigua and Barbuda Aruba Bahamas, The Barbados Belize Bermuda Canada Cayman.
Advertisements

Volume 385, Issue 9963, Pages (January 2015)
ALL Justice for Our Neighbors Case Data as of August 31, 2015
Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Stomach cancer burden in Central and South America
Classification of Schmorl's nodes of the lumbar spine and association with disc degeneration: a large-scale population-based MRI study  D. Samartzis,
Volume 80, Issue 1, Pages (July 2011)
Volume 389, Issue 10076, Pages (April 2017)
Soyoun Kim, Jaewon Hwang, Daeyeol Lee  Neuron 
Volume 80, Issue 1, Pages (July 2011)
Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment 
Simon Sawhney, Simon D. Fraser  Advances in Chronic Kidney Disease 
Associations of ambient coarse particulate matter, nitrogen dioxide, and carbon monoxide with the risk of kidney disease: a cohort study  Benjamin Bowe,
The Global Burden of Skin Disease in 2010: An Analysis of the Prevalence and Impact of Skin Conditions  Roderick J. Hay, Nicole E. Johns, Hywel C. Williams,
Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology.
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden.
Henry W. Lim, MD, Scott A. B. Collins, MD, Jack S. Resneck, MD, Jean L
A systematic analysis of global anemia burden from 1990 to 2010
Volume 92, Issue 1, Pages (July 2017)
High prevalence of chronic kidney disease in Thailand
The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015  Chante Karimkhani, MD, Danny V Colombara, PhD,
Lauren M Gardner, Nan Chen, Sahotra Sarkar 
Volume 72, Issue 5, Pages (September 2007)
Simon Sawhney, Simon D. Fraser  Advances in Chronic Kidney Disease 
Gabriel J Milinovich, Ricardo J Soares Magalhães, Wenbiao Hu 
The 2016 global and national burden of diabetes mellitus attributable to PM2·5 air pollution  Benjamin Bowe, MPH, Yan Xie, MPH, Tingting Li, MD, Prof.
Recognition for Conservative Care in Kidney Failure
John P. Middleton, Patrick H. Pun  Kidney International 
CKD and Poverty: A Growing Global Challenge
MMR1 reported coverage Non-Latin Caribbean, 2013
Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002–11, and requirements.
The Erasmus Programme: from Europe to Africa
Burden of chronic kidney disease: North Africa
Quiz Page November 2008 American Journal of Kidney Diseases
Global disability-adjusted life-year estimates of long-term health burden and undernutrition attributable to diarrhoeal diseases in children younger than.
The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015  Chante Karimkhani, MD, Danny V Colombara, PhD,
Chronic Kidney Disease in Long-Term Survivors after Allogeneic Hematopoietic Stem Cell Transplantation: Retrospective Analysis at a Single Institute 
GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration 
Change in bone area does not correlate with cartilage loss over 12 months in individuals with knee OA: Data from the osteoarthritis initiative  M.A. Bowes,
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Volume 75, Issue 10, Pages (May 2009)
Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian, Yan Yan, Ziyad Al-Aly 
Classification of Schmorl's nodes of the lumbar spine and association with disc degeneration: a large-scale population-based MRI study  D. Samartzis,
Volume 70, Issue 11, Pages (December 2006)
Gary C.W. Chan, Sydney C.W. Tang  Kidney International 
Socioeconomic Status and Reduced Kidney Function in the Whitehall II Study: Role of Obesity and Metabolic Syndrome  Talal M. Al-Qaoud, MD, MSc, Dorothea.
Measuring population ageing: an analysis of the Global Burden of Disease Study 2017  Angela Y Chang, ScD, Prof Vegard F Skirbekk, PhD, Stefanos Tyrovolas,
The epidemiology of chronic kidney disease
Use of vitamin D in chronic kidney disease patients
Donna L. Mapes, DNSc, Jennifer L
H. Wong, K. Mylrea, J. Feber, A. Drukker, G. Filler 
A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico
Volume 70, Issue 12, Pages (December 2006)
Volume 18, Issue 3, Pages (March 2019)
GBD 2016 estimates problematic for South Africa
Methods for guideline development
Cardiovascular disease in pediatric chronic dialysis patients
The global challenge of chronic kidney disease
Cell Growth and Size Homeostasis in Silico
Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell  Kara K. Wools-Kaloustian, Samir K. Gupta  Kidney.
Volume 6, Issue 6, Pages e382-e395 (June 2019)
Opportunities for a chronic disease outreach program in China
Molecular Similarity Analysis Uncovers Heterogeneous Structure-Activity Relationships and Variable Activity Landscapes  Lisa Peltason, Jürgen Bajorath 
Vitamin D deficiency and anemia in early chronic kidney disease
Volume 71, Issue 7, Pages (April 2007)
Minimal improvements in the global burden of skin disease from 1990 to 2013  Jessica Mounessa, Taylor Braunberger, MD, Cory A. Dunnick, MD, Robert P. Dellavalle,
A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan  Yi-Chun.
This Month in AJKD American Journal of Kidney Diseases
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Volume 94, Issue 3, Pages 567-581 (September 2018) Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016  Yan Xie, Benjamin Bowe, Ali H. Mokdad, Hong Xian, Yan Yan, Tingting Li, Geetha Maddukuri, Cheng-You Tsai, Tasheia Floyd, Ziyad Al- Aly  Kidney International  Volume 94, Issue 3, Pages 567-581 (September 2018) DOI: 10.1016/j.kint.2018.04.011 Copyright © 2018 Terms and Conditions

Kidney International 2018 94, 567-581DOI: (10.1016/j.kint.2018.04.011) Copyright © 2018 Terms and Conditions

Figure 1 (a) Worldwide prevalence of chronic kidney disease (CKD). (b) Worldwide age-standardized prevalence rate of CKD. Rate is per 100,000 population. ATG, Antigua and Barbuda; FSM, Federated States of Micronesia; Isl, Island; LCA, Saint Lucia; TLS, Timor-Leste; TTO, Trinidad and Tobago; VCT, Saint Vincent and the Grenadines. Heat gradient represents deciles from red (highest) to blue (lowest). Kidney International 2018 94, 567-581DOI: (10.1016/j.kint.2018.04.011) Copyright © 2018 Terms and Conditions

Figure 2 Chronic kidney disease (CKD) prevalence rate across age groups at the global level and by Sociodemographic Index (SDI) quintiles. Rate is per 100,000 population. Kidney International 2018 94, 567-581DOI: (10.1016/j.kint.2018.04.011) Copyright © 2018 Terms and Conditions

Figure 3 Changes in chronic kidney disease (CKD) disability-adjusted life-years (DALYs) according to population-level determinants of population growth, aging, and epidemiological change from 1990 to 2016 at the global level and by Sociodemographic Index (SDI) quintile. The black dot represents the overall value of change contributed by all 3 components. For each component, the magnitude of a positive value indicates a corresponding increase in CKD DALYs attributed to the component; the magnitude of a negative value indicates a corresponding decrease in CKD DALYs attributed to the related component. Kidney International 2018 94, 567-581DOI: (10.1016/j.kint.2018.04.011) Copyright © 2018 Terms and Conditions

Figure 4 Changes in chronic kidney disease (CKD) disability-adjusted life-years (DALYs) according to the 4 causes from 1990 to 2016 at the global level and by Sociodemographic Index (SDI) quintile. The black dot represents the overall value of change contributed by all 4 causes. For each component, the magnitude of a positive value indicates a corresponding increase in CKD DALYs attributed to the component; the magnitude of a negative value indicates a corresponding decrease in CKD DALYs attributed to the related component. Kidney International 2018 94, 567-581DOI: (10.1016/j.kint.2018.04.011) Copyright © 2018 Terms and Conditions

Figure 5 Association between age-standardized chronic kidney disease (CKD) disability-adjusted life-years (DALY) rate and Healthcare Access and Quality index. Each circle represents a country; circles are colored according to Sociodemographic Index (SDI) quintile; circle size corresponds to population number. Kidney International 2018 94, 567-581DOI: (10.1016/j.kint.2018.04.011) Copyright © 2018 Terms and Conditions

Figure 6 (a) Frontier analysis based on Sociodemographic Index (SDI) and age-standardized chronic kidney disease (CKD) disability-adjusted life-years (DALY) rate from 1990 to 2016. Color scale represents the years from 1990 depicted in gray to 2016 depicted in green. The frontier is delineated in solid black color. (b) Frontier analysis based on SDI and age-standardized CKD DALY rate in 2016. The frontier is delineated in solid black color; countries and territories are represented as dots. The top 15 countries with the largest effective difference (largest CKD DALYs gap from the frontier) are labeled in black; examples of frontier countries with low SDI (<0.5) and low effective difference are labeled in blue (e.g., South Sudan, Burundi, Democratic Republic of Congo, Madagascar, Rwanda, and Nigeria), and examples of countries and territories with high SDI (>0.85) and relatively high effective difference for their level of development are labeled in red (e.g., United States, Puerto Rico, US Virgin Islands, Brunei, and Taiwan). Red dots indicate an increase in age-standardized CKD DALY rate from 1990 to 2016; blue dots indicate a decrease in age-standardized CKD DALY rate between 1990 and 2016. DRC, Democratic Republic of Congo. Kidney International 2018 94, 567-581DOI: (10.1016/j.kint.2018.04.011) Copyright © 2018 Terms and Conditions